However, this conclusion could not be confirmed by the research of FitzGerald et al., who observed no positive correlation between FGFR4 G388R or V10I polymorphisms and prostate cancer susceptibility in Caucasians or African Americans23. Here, FGFR4 is linked to prostate carcinoma.